Rangers starter
Nathan Eovaldi has undergone surgery to repair a sports hernia, reports
Jeff Wilson of DLLS Sports. GM Ross Fenstermaker revealed
earlier this month that the righty would be meeting with a specialist to determine the best course of treatment, and evidently, surgery was the conclusion they came to. Willson suggests that the Rangers expect Eovaldi to be fully recovered from the hernia surgery (and the
strained rotator cuff that ended his season in August) by the time spring training rolls around, presuming he suffers no setbacks.
In addition to the rotator cuff strain, Eovaldi also missed a month earlier in the season with what was originally labelled a triceps issue and later diagnosed as posterior elbow inflammation. When he took the mound, however, the 35-year-old looked better than ever in his 14th big league season. He finished with a 1.73 ERA in 22 starts. Like his ERA, his xERA and SIERA were also career-bests. His velocity was down, but he compensated with pristine command, walking just 4.2% of the batters he faced, and he still did a phenomenal job of missing bats and inducing soft contact. If it weren’t for the time he missed, Eovaldi likely would have been a strong contender for the AL Cy Young, and even so, there’s a good chance he’ll earn some votes for just the second time in his career.
Eovaldi’s health will be paramount for the Rangers in 2026. RosterResource estimates that the team has about $45MM coming off the books this winter, but it doesn’t seem like ownership is ready to foot the bill for a high-spending offseason. When Bruce Bochy stepped down as manager, president of baseball operations Chris Young
explained that the team would be focusing on youth moving forward, citing “financial uncertainty.” That certainly suggests that Texas won’t be making many major additions in the coming months. So, if the Rangers want any hope of improving upon a second straight mediocre finish and contending in 2026, the stars who are already under contract will need to put the team on their back. A full, healthy season from Eovaldi – especially the version of Eovaldi on display in 2025 – would go a long way for this team in 2026.
